Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/312
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Polycyclo ring system having the six-membered hetero ring as one of the cyclos > Bicyclo ring system having the six-membered hetero ring as one of the cyclos > Quinolines (including hydrogenated) > Chalcogen attached directly to the six-membered hetero ring by nonionic bonding
Description: Subject matter wherein chalcogen (i.e., oxygen, sulfur, selenium or tellurium) is attached directly to the six-membered hetero ring of the quinoline ring system by nonionic bonding.










Patents under this class:

Patent Number Title Of Patent Date Issued
8710079 Quinoline compounds and their use for treating viral infection Apr. 29, 2014
8703798 Antifungal and antiparasitic indoloquinoline derivatives Apr. 22, 2014
8703156 Liquid formulation for deferiprone with palatable taste Apr. 22, 2014
8691843 Antioxidant combinations for use in ruminant feed rations Apr. 8, 2014
8686001 Medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol Apr. 1, 2014
8685983 Method of treating cancer with substituted amide derivatives Apr. 1, 2014
8685971 Quinolinyloxyphenylsulfonamides Apr. 1, 2014
8685960 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase CYP11B2 Apr. 1, 2014
8680117 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents Mar. 25, 2014
8680116 Quinolinone PDE2 inhibitors Mar. 25, 2014
8680115 Tetrahydroquinoline analogues as muscarinic agonists Mar. 25, 2014
8680114 AKT protein kinase inhibitors Mar. 25, 2014
8673937 Eye-drop preparation and use thereof Mar. 18, 2014
8673322 Crystals of laquinimod sodium, and process for the manufacture thereof Mar. 18, 2014
8669273 Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine Mar. 11, 2014
8664244 Compounds as c-Met kinase inhibitors Mar. 4, 2014
8658673 BETA2-adrenoreceptor agonists Feb. 25, 2014
8658670 Methods and compounds for treatment of clostridium based infection Feb. 25, 2014
8658645 Use of quinolone antibiotics Feb. 25, 2014
8658639 N-substituted-cyclic amino derivative Feb. 25, 2014
8658183 Antimicrobial parenteral formulation Feb. 25, 2014
8653104 PTEN inhibitor or Maxi-K channels opener Feb. 18, 2014
8653103 Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid Feb. 18, 2014
8653102 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators Feb. 18, 2014
8653101 Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators Feb. 18, 2014
8653069 Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia Feb. 18, 2014
8648093 Salt and crystalline forms thereof of a drug Feb. 11, 2014
8648091 Dihydroquinolinones as ectoparasiticides Feb. 11, 2014
8647646 Crystals of laquinimod sodium, and process for the manufacture thereof Feb. 11, 2014
8642660 Method for altering the lifespan of eukaryotic organisms Feb. 4, 2014
8642619 Quinolone compound and pharmaceutical composition Feb. 4, 2014
8642618 Carbostyril derivatives including cilostazol for treating fatty liver Feb. 4, 2014
8642613 Treatment for leukemia and idiopathic aplastic anemia Feb. 4, 2014
8637567 Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid Jan. 28, 2014
8633220 Therapeutic agents for ocular hypertension Jan. 21, 2014
8633219 Combination therapy Jan. 21, 2014
8629162 Modulators of ATP-binding cassette transporters Jan. 14, 2014
8629126 Quinolone derivative or pharmaceutically acceptable salt thereof Jan. 14, 2014
8629102 3-hydroxyisothiazole 1-oxide derivatives Jan. 14, 2014
8623894 Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3- -carboxamide Jan. 7, 2014
8623893 Pyridino-pyridinone derivatives, preparation and therapeutic use thereof Jan. 7, 2014
8618131 Biphenyl derivatives Dec. 31, 2013
8618094 Fused substituted aminopyrrolidine derivative Dec. 31, 2013
8617606 Hydrogel suspension and manufacturing process thereof Dec. 31, 2013
8614230 Derivatives of the aminated hydroxyquinoline class for treating cancers Dec. 24, 2013
8604056 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors Dec. 10, 2013
8604055 Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors Dec. 10, 2013
8604030 Fused piperidine compound and pharmaceutical containing same Dec. 10, 2013
8598205 Modulators of cystic fibrosis transmembrane conductance regulator Dec. 3, 2013
8598204 1,2-dihydro-2-oxoquinoline compounds as 5-HT.sub.4 receptor ligands Dec. 3, 2013











 
 
  Recently Added Patents
Washing-up bowl
Method and system and policy server for guaranteeing data not to be interrupted
Air driven alternators for battery powered vehicles
Carrying case
Case for electronic device
Vending machine
LED-array package
  Randomly Featured Patents
Audio earpiece and peripheral devices
Probe method for measuring part to be measured by use thereof and electrical circuit member
Manganese containing oxygen storage component comprising three-way catalyst composition
Process and apparatus for heating glass sheets
Turbocharger comprising a variable nozzle device
Sweetening agent derived from L-aspartic or L-glutamic acid
Modular data sensing and logging system
Active matrix liquid crystal display and method of driving the same and electronic device
Table
Intra-cavity optical four-wave mixer and optical communications system using the same